Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study

Gastrointestinal Endoscopy

Volumn 57, Issue 3, 2003, Pages 291-294

  Fazel, Ali ^a   Quadri, Affan ^a   Catalano, Marc F ^a   Meyerson, Scott M ^a   Geenen, Joseph E ^a,b  

^a St Luke's Hospital Milwaukee   (United States)

^b ST LUKE S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABEXATE MESILATE; OCTREOTIDE;

ADULT; AGED; ARTICLE; CANNULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MANOMETRY; ODDI SPHINCTER; PANCREAS DUCT; PANCREAS DUCT STENOSIS; PANCREATITIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STENT;

EID: 0037344269     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2003.124     Document Type: Article

References (10)

1. Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991;37:383-93.
2. Cavallini G, Tittobello A, Frulloni L, Masci E, Mariana A, Di Francesco V. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med 1996;335:919-23.
3. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, et al. Complication of biliary endoscopic sphincterotomy. N Engl J Med 1996;335:909-18.
4. Chen YK, Foliente RL, Santoro MJ, Walter MH, Collen MJ. Endoscopic sphincterotomy-induced pancreatitis: increased risk associated with nondilated bile ducts and sphincter of Oddi dysfunction. Am J Gastroenterol 1994;89:327-33.
5. Sherman S, Lehman G. ERCP and endoscopic sphincterotomy-induced pancreatitis. Pancreas 1991;6:350-67.
6. Tarnasky PR, Palesch YY, Cunningham JT, Mauldin PD, Cotton PB, Hawes RH. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998;115:1518-24.
7. Sherman S, Earle D, Bucksot L, Esber E, Hawes R, Lehman G. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy induced pancreatitis? Am J Gastroenterol 1995;90:1614.
8. Smithline A, Silverman W, Rogers D, Nisi R, Wiersema M, Jamidar P, et al. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high risk patients. Gastrointest Endosc 1993;39:652-7.
9. Kingsworth A. Role of cytokines and their inhibitors in acute pancreatitis. Gut 1997;40:1-4.
10. Andriulli A, Leandro G, Niro G, Mangia A, Festa V, Gambassi G, et al. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc 2000;51:1-7.